On the Safety of 5-[¹²⁵I]IODO-2'-Deoxyuridlne: Preclinical evaluation in swine

References

• Baranowska-Kortylewicz J., Makrigiorgos G. M., Van den Abbeele A. D., Berman R. M., Adelstein S. J., Kassis A. I. 5-[123I]Iodo-2'-deoxyuridine in the radiotherapy of an early ascites tumor model. Int J Oncol Biol Phys 1991; 21: 1541–51
   PubMed Web of Science ®Google Scholar
• Commerford S. L. Biological stability of 5-iodo-2'-deoxy-uridine labelled with iodine-125 after its incorporation into the deoxyribonucleic acid of the mouse. Nature 1965; 206: 949–50
   PubMed Web of Science ®Google Scholar
• Bloomer W. D., Adelstein S. J. Therapeutic application of iodine-125 labeled iododeoxyuridine in an early ascites tumor model. Curr Top Radiat Res Q 1978; 12: 513–25
   PubMedGoogle Scholar
• Humm J. L., Bagshawe K. D., Sharma S. K., Boxer G. Tissue dose estimates following the selective uptake of 125IUdR and other radiolabelled thymidine precursors in resistant tumors. Br J Radiol 1991; 64: 45–9
   PubMed Web of Science ®Google Scholar
• Mariani G., Di Sacco S., Volterrani D., et al. Tumor targeting with 5-[123I]iodo-2' deoxyuridine infused into the hepatic artery of patients with liver metastases from colorectal cancer. J Nucl Biol Med 1994; 38: 265–7
   Google Scholar
• Rezvani M., Hopewell J. W. The response of the pig lung to fractionated doses of X rays. Br J Radiol 1990; 63: 41–50
   PubMedGoogle Scholar
• Miot E., Hoffschir D., Pontvert D., et al. Quantitative magnetic resonance and isotopic imaging: early evaluation of radiation injury to the brain. Int J Radiat Oncol Biol Phys 1995; 32: 121–8
   PubMed Web of Science ®Google Scholar
• Novotny J., Otoupal P., Mika J., Hrusovsky J. Dose measurement in animal experiments. II. Dose distribution in 60Co irradiated pigs. Strahlentherapie 1972; 144: 430–4
   PubMedGoogle Scholar
• Ragan H. A., Palotay J. L., Clarke W. J. Effects of radioiodine in sheep and swine. BNWL Rep 1966; 1: 38–40
   Google Scholar
• Young C. M., Hopewell J. W. The isotope clearance technique for measuring skin blood flow. Br J Plast Surg 1983; 36: 222–30
   PubMedGoogle Scholar
• Hopewell J. W., Berry R. J. Radiation tolerance of the pig kidney: a model for determining overall time and fraction factors for preserving renal function. Int J Radiat Oncol Biol Phys 1975; 1: 61–8
   PubMedGoogle Scholar
• McLaughlin R. F., Styler W. S., Canada R. O. A study of the subgross pulmonary anatomy in various mammals. Am J Anatomy 1961; 108: 149–65
   Google Scholar
• Sperber I. Studies on the mammalian kidney. Zoologiska Bidrag frän Uppsala 1944; 22: 249–431
   Google Scholar
• Terris J. M. Swine as a model in renal physiology and nephrology: a review. Swine in biomedical research, M. E. Tumbleson. Plenum Press, New York 1986; 1673–89
   Google Scholar
• Douglas B. G., Grulkey W. R., Chaplin D. J., Lam G., Skarsgard L. D., Denekamp J. Pions and pig skin: Preclinical evaluation of RBE for early and late damage. Int J Radiat Oncol Biol Phys 1986; 12: 221–9
   PubMed Web of Science ®Google Scholar
• Scharl A., Beckmann M. W., Artwohl J. E., Holt J. A. Comparison of radioiodoestradiol blood-tissue exchange after intravenous or intraarterial injection. Int J Radiat Oncol Biol Phys 1995; 32: 137–46
   PubMedGoogle Scholar
• Baranowska-Kortylewicz J., Helseth L. D., Lai J., Schneiderman M. H., Schneiderman G. S., Dalrymple G. V. Radiolabeling kit/generator for 5-radiohalogenated uridines. (Baranowska-Kortylewicz J., U. S. Patent 5,468, 853; 1995) J Labelled Compds Radiopharm 1994; 34: 513–21
   Web of Science ®Google Scholar
• Chang A., Hammond T. G., Sun T. T., Zeidel M. L. Permeability properties of the mammalian bladder apical membrane. Am J Physiol 1994; 267: 1483–92
   Google Scholar
• Horn Y., Eidelman A., Walach N., Waron M., Barak F. Intravesical chemotherapy of superficial bladder tumors in a controlled trial with cis-platinum versus cis-platinum plus hyaluronidase. J Surg Oncol 1985; 28: 304–7
   PubMed Web of Science ®Google Scholar
• Siegmund O. H. The Merck Veterinary Manual. Merck and Co, Railway, NJ 1986; 966–70
   Google Scholar
• Speth P. A., Kinsella T. J., Chang A. E., Klecker R. W., Belanger K., Collins J. M. Selective incorporation of iododeoxyuridine into DNA of hepatic metastases versus normal human liver. Clin Pharmacol Ther 1988; 44: 369–75
   PubMed Web of Science ®Google Scholar
• Remick S. C., Benson A. B., Weese J. L. Phase I trial of hepatic artery infusion of 5-iodo-2'-deoxyuridine and 5-fluorouracil in patients with advanced hepatic malignancy: biochemically based combination therapy. Cancer Res 1989; 49: 6437–42
   PubMedGoogle Scholar
• Gebarski H. S., Chandler W. F., Diaz R. F. Intra-arterial bromod-eoxyuridine radiosensitization and radiation in treatment of malignant astrocytomas. J Neurosurg 1988; 69: 500–5
   PubMedGoogle Scholar
• Klapper P. E., Cleator G. M., Bruce J. M., Longson M. Penetration of the blood-brain barrier by the antiviral drug E-5-(2-vinyl)-2'-iodo-deoxyuridine in a rat model of herpes encephalitis. Drug Des Deliv 1988; 3: 57–67
   PubMedGoogle Scholar
• Greenberg H. S., Chandler W. F., Ensminger W. D. Radiosensitization with carotid intra-arterial bromodeoxyuridine ±5-fluorouracil biomodulation for malignant gliomas. Neurology 1994; 44: 1715–20
   PubMedGoogle Scholar